Life Sciences Panel Discussion Pfizers approach to External - - PowerPoint PPT Presentation

▶

May 07, 2023 133 likes •215 views

Life Sciences Panel Discussion Pfizers approach to External Innovation and Pharmaceutical Drug Discovery Global 1000 Conference and Showcase 2013 Ron Newbold VP External R&D Innovation Pfizer Worldwide Research March 20, 2014 Pfizers

SLIDE 1

Life Sciences Panel Discussion

Pfizer’s approach to External Innovation and Pharmaceutical Drug Discovery

Global 1000 Conference and Showcase 2013

Ron Newbold VP External R&D Innovation Pfizer Worldwide Research March 20, 2014

SLIDE 2

Pfizer’s Purpose and Mission

Our Mission To Be the Premier, Innovative Biopharmaceutical Company Our Purpose Innovate to bring therapies to patients that significantly improve their lives

SLIDE 3

Quality of Output Probability of Success Speed Cost

Comprehensive Effort to Accelerate the R&D Strategy

Greater Focus

to strengthen

ur scientific core

Strategic Externalization

for competitive advantage

ESI: Engine for Sustainable Innovation

2 1 3

Differentiated Innovation through culture,

leadership, Precision Medicine

SLIDE 4

Pfizer Major Research Focus Areas

R&D Core Areas

Inflammation & Remodelling Immunology & Autoimmunity Cardio- Vascular, Metabolic & Endocrine Disease Neuroscience Oncology

Specialized Areas

Anti-Bacterials Anti-Virals (Asia R&D) Biosimilars Pain & Sensory Disorders Stem Cells (Neusentis) Vaccines Orphan & Rare Diseases

SLIDE 5

Partnering on Next Generation Technologies to Enhance Existing / New Modalities

Immunology & Inflammation Cardiovascular & Metabolic Diseases Oncology Vaccines Neuroscience & Pain Rare Diseases

SLIDE 6

Pfizer Global Seed Fund

Develop a pipeline of External Opportunities that External R&D builds with our Research Units – support earlier-stage science

U.Va. Spinoff Neoantigenics Announces Collaboration with Pfizer, Investment from CIT to Develop Antibody-based Therapeutics For Cancer January 28, 2014

SLIDE 7

ERDI - Partnering with Pfizer Worldwide R&D

www.Pfizer.com/WRDpartnering

Scientific team with dedicated external focus
Centralized hub for external partners and

internal research & business leaders in the Idea - POC space (“One-stop-shopping”)

Defines External R&D Strategies with RUs

and PartnerLines

Executes globally against high priority needs:

Identify and prosecute late-breaking science, breakthrough technologies, and quality assets that deliver value to Pfizer Partnering in the Idea – PoC space provides challenges by

number of global opportunities
limited publicly available information